SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-006966
Filing Date
2020-05-07
Accepted
2020-05-07 16:26:35
Documents
82
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gh-03312020x10q.htm   iXBRL 10-Q 1704121
2 EXHIBIT 31.1 gh-0331x2020x10qxexhib311.htm EX-31.1 13170
3 EXHIBIT 31.2 gh-0331x2020x10qxexhib312.htm EX-31.2 13186
4 EXHIBIT 32.1 gh-0331x2020x10qxexhib321.htm EX-32.1 6943
5 EXHIBIT 32.2 gh-0331x2020x10qxexhib322.htm EX-32.2 6942
  Complete submission text file 0001628280-20-006966.txt   8489406

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20200331.xsd EX-101.SCH 49428
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20200331_cal.xml EX-101.CAL 102202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20200331_def.xml EX-101.DEF 283153
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20200331_lab.xml EX-101.LAB 720272
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20200331_pre.xml EX-101.PRE 446479
54 EXTRACTED XBRL INSTANCE DOCUMENT gh-03312020x10q_htm.xml XML 1657160
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 20856876
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences